| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule binding | 3.90e-04 | 308 | 23 | 4 | GO:0008017 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.33e-03 | 428 | 23 | 4 | GO:0015631 | |
| GeneOntologyMolecularFunction | actin binding | 2.02e-03 | 479 | 23 | 4 | GO:0003779 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.17e-03 | 227 | 23 | 3 | GO:0051015 | |
| Domain | Plectin_repeat | 6.50e-08 | 7 | 24 | 3 | IPR001101 | |
| Domain | Plectin | 6.50e-08 | 7 | 24 | 3 | PF00681 | |
| Domain | PLEC | 6.50e-08 | 7 | 24 | 3 | SM00250 | |
| Domain | Spectrin_repeat | 6.66e-06 | 29 | 24 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 9.02e-06 | 32 | 24 | 3 | IPR018159 | |
| Domain | SPEC | 9.02e-06 | 32 | 24 | 3 | SM00150 | |
| Domain | GAR | 2.37e-05 | 6 | 24 | 2 | PS51460 | |
| Domain | - | 2.37e-05 | 6 | 24 | 2 | 3.30.920.20 | |
| Domain | - | 2.37e-05 | 6 | 24 | 2 | 3.90.1290.10 | |
| Domain | GAS_dom | 2.37e-05 | 6 | 24 | 2 | IPR003108 | |
| Domain | GAS2 | 2.37e-05 | 6 | 24 | 2 | PF02187 | |
| Domain | GAS2 | 2.37e-05 | 6 | 24 | 2 | SM00243 | |
| Domain | CH | 7.73e-05 | 65 | 24 | 3 | SM00033 | |
| Domain | CH | 9.64e-05 | 70 | 24 | 3 | PF00307 | |
| Domain | - | 1.01e-04 | 71 | 24 | 3 | 1.10.418.10 | |
| Domain | CH | 1.09e-04 | 73 | 24 | 3 | PS50021 | |
| Domain | CH-domain | 1.18e-04 | 75 | 24 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 3.94e-04 | 23 | 24 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 3.94e-04 | 23 | 24 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.94e-04 | 23 | 24 | 2 | PS00019 | |
| Domain | BTB | 1.22e-02 | 131 | 24 | 2 | PF00651 | |
| Domain | BTB | 1.78e-02 | 160 | 24 | 2 | PS50097 | |
| Pathway | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | 1.38e-04 | 12 | 21 | 2 | MM14908 | |
| Pathway | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | 1.38e-04 | 12 | 21 | 2 | M3634 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 2.19e-04 | 15 | 21 | 2 | MM14536 | |
| Pubmed | 4.09e-07 | 1084 | 24 | 8 | 11544199 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 17662978 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 11854008 | ||
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 1.12e-05 | 63 | 24 | 3 | 29162697 | |
| Pubmed | 1.27e-05 | 8 | 24 | 2 | 23039181 | ||
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 1.58e-05 | 223 | 24 | 4 | 33187986 | |
| Pubmed | 1.64e-05 | 9 | 24 | 2 | 15500642 | ||
| Pubmed | 1.78e-05 | 486 | 24 | 5 | 20936779 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.97e-05 | 853 | 24 | 6 | 28718761 | |
| Pubmed | 3.69e-05 | 277 | 24 | 4 | 30745168 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 4.47e-05 | 100 | 24 | 3 | 25807483 | |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 6.43e-05 | 113 | 24 | 3 | 34474245 | |
| Pubmed | 9.16e-05 | 686 | 24 | 5 | 29987050 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 1.59e-04 | 1242 | 24 | 6 | 30973865 | |
| Pubmed | 1.71e-04 | 28 | 24 | 2 | 30037996 | ||
| Pubmed | 1.81e-04 | 418 | 24 | 4 | 34709266 | ||
| Pubmed | 1.83e-04 | 29 | 24 | 2 | 36800290 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 1.87e-04 | 162 | 24 | 3 | 14743216 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.96e-04 | 807 | 24 | 5 | 30575818 | |
| Pubmed | Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. | 2.83e-04 | 36 | 24 | 2 | 16097034 | |
| Pubmed | 3.08e-04 | 481 | 24 | 4 | 28190767 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.21e-04 | 1415 | 24 | 6 | 28515276 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.89e-04 | 208 | 24 | 3 | 33230847 | |
| Pubmed | 3.94e-04 | 209 | 24 | 3 | 36779422 | ||
| Pubmed | 4.00e-04 | 210 | 24 | 3 | 16565220 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 4.11e-04 | 212 | 24 | 3 | 33462405 | |
| Pubmed | 4.84e-04 | 47 | 24 | 2 | 15172686 | ||
| Pubmed | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. | 4.84e-04 | 47 | 24 | 2 | 29934401 | |
| Pubmed | 5.21e-04 | 230 | 24 | 3 | 35449600 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.28e-04 | 231 | 24 | 3 | 16452087 | |
| Pubmed | 5.48e-04 | 234 | 24 | 3 | 36243803 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 5.66e-04 | 565 | 24 | 4 | 25468996 | |
| Pubmed | 6.04e-04 | 242 | 24 | 3 | 34011540 | ||
| Pubmed | 6.69e-04 | 591 | 24 | 4 | 15231748 | ||
| Pubmed | 6.72e-04 | 251 | 24 | 3 | 28077445 | ||
| Interaction | PSMD14 interactions | 2.15e-05 | 527 | 23 | 6 | int:PSMD14 | |
| Cytoband | 16p13.3 | 7.19e-03 | 244 | 24 | 2 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 2.07e-02 | 426 | 24 | 2 | chr16p13 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.18e-08 | 8 | 16 | 3 | 939 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 6.11e-03 | 134 | 16 | 2 | 861 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 3.29e-06 | 32 | 24 | 3 | MM1307 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 3.29e-06 | 32 | 24 | 3 | M2334 | |
| Coexpression | GSE2706_UNSTIM_VS_2H_R848_DC_UP | 2.81e-05 | 195 | 24 | 4 | M4691 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 2.66e-05 | 156 | 24 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-06 | 199 | 24 | 4 | c9d15c84b9f8c87b4ea0008be7d5efc5f45efd1a | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 159 | 24 | 3 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 178 | 24 | 3 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 181 | 24 | 3 | 0c52dd82e6b3dce3d6bb5c13501bf8383f7121e4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 24 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 184 | 24 | 3 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 185 | 24 | 3 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 185 | 24 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-04 | 185 | 24 | 3 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 24 | 3 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 24 | 3 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 190 | 24 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 192 | 24 | 3 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.47e-04 | 193 | 24 | 3 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | facs-Marrow-B-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | 24c34c6635eb7fc2878282803c421b64320e77d8 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 194 | 24 | 3 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 194 | 24 | 3 | 7ee8ac172c2dee7df7dc4eb222e0985a0089bda8 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-B_intermediate|ICU-NoSEP / Disease, condition lineage and cell class | 1.61e-04 | 199 | 24 | 3 | 97a32b664c89e865cf29f83add794d277fa020cd | |
| Drug | plakin | 1.57e-06 | 82 | 24 | 4 | CID000018752 | |
| Drug | Cilligen | 1.59e-05 | 6 | 24 | 2 | CID003085040 | |
| Drug | AC1L1X4J | 2.97e-05 | 8 | 24 | 2 | CID000011330 | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 4826_DN | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; PC3; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 5816_UP | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; PC3; HT_HG-U133A | 5.14e-05 | 198 | 24 | 4 | 4576_DN | |
| Drug | 1-methylphenanthrene | 5.82e-05 | 11 | 24 | 2 | CID000013257 | |
| Disease | response to methotrexate, neurotoxicity | 1.08e-04 | 19 | 24 | 2 | EFO_0011057, GO_0031427 | |
| Disease | Leber Congenital Amaurosis | 1.45e-04 | 22 | 24 | 2 | C0339527 | |
| Disease | cancer (implicated_via_orthology) | 1.30e-03 | 268 | 24 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | metabolite measurement, diet measurement | 1.52e-03 | 71 | 24 | 2 | EFO_0004725, EFO_0008111 | |
| Disease | thyroid peroxidase antibody measurement | 1.57e-03 | 72 | 24 | 2 | EFO_0005666 | |
| Disease | Disproportionate short stature | 1.79e-03 | 77 | 24 | 2 | C0878659 | |
| Disease | migraine disorder | 2.94e-03 | 357 | 24 | 3 | MONDO_0005277 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.17e-03 | 103 | 24 | 2 | EFO_0008595, EFO_0020944 | |
| Disease | eosinophil measurement | 3.48e-03 | 108 | 24 | 2 | EFO_0803540 | |
| Disease | interleukin-6 measurement | 3.73e-03 | 112 | 24 | 2 | EFO_0004810 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.34e-03 | 121 | 24 | 2 | EFO_0008595, EFO_0020943 | |
| Disease | loneliness measurement | 4.55e-03 | 124 | 24 | 2 | EFO_0007865 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 4.77e-03 | 127 | 24 | 2 | EFO_0008595, EFO_0020947 | |
| Disease | total blood protein measurement | 5.59e-03 | 449 | 24 | 3 | EFO_0004536 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IAEQFMQQKLDLGCA | 241 | Q5H9S7 | |
| ERNQLKACMGELLDN | 691 | Q9BYV9 | |
| ENMCNLQKLNLAGNE | 166 | Q7Z7A1 | |
| ELLKLMCELGNSAVN | 466 | Q96P50 | |
| EGLSKMRQENFLCDL | 61 | Q9H511 | |
| LCEGMKLLASDLLDN | 686 | Q14164 | |
| KGQELAAMACELQAQ | 651 | O60437 | |
| NKGMEEGEDNLLCNL | 976 | Q9H0H0 | |
| VCALQNEFLGKDMLI | 2786 | Q9UPN3 | |
| QIDSGDLMECLIQNK | 711 | Q92896 | |
| LNVMKGCLANQADLD | 271 | Q9Y625 | |
| NLLGLLDNDEIMALC | 16 | Q5JPI3 | |
| CLNLLNEELEELNMK | 146 | A6NGH7 | |
| NLLEMTFECQNLGKL | 976 | Q6ZUT9 | |
| DQLLDSMKEIGSNCL | 46 | P13232 | |
| CKENGLDDQLMNLAL | 1046 | Q96RY7 | |
| TFMEKLDNGALLCQL | 56 | O43903 | |
| CAQDLAMKDELLCQL | 746 | Q96R06 | |
| SLNDLEKDVMLLCQN | 1521 | P51532 | |
| ELLMGNNKLLCENCT | 631 | Q70EL2 | |
| TKLQMEAGLCEEQLN | 536 | Q15149 | |
| AKLLRDMNQGELFDC | 146 | Q96JH7 | |
| DQGQELLCCKMALLT | 146 | Q969J2 | |
| NNLDPELKNLFDMCG | 226 | O00401 |